SCHEMBL2825924

SCHEMBL2825924

NC(=O)c1cccc(Br)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
HPGD P15428 1/20 0.49
GRM5 P41594 1/20 0.47
PIM1 P11309 1/20 0.47
KDM4E B2RXH2 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
ACMSD Q8TDX5 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PARP1 P09874 2/20 0.41
GRM2 Q14416 2/20 0.39
LMNA P02545 1/20 0.39
CTSA P10619 1/20 0.38
NNMT P40261 1/20 0.38
SCN9A Q15858 1/20 0.37
DGAT1 O75907 1/20 0.36
P2RX7 Q99572 1/20 0.36
HTR2B P41595 1/20 0.36
MAPK10 P53779 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL13837126 0.88 ALDH1A1 (0.44) ALDH1A1HPGDGRM5PIM1KDM4E
Pyridine Dicarboxamide SCHEMBL229425 0.84 TSHR (0.59) ALDH1A1PIM1KDM4EALOX15TSHR
Pyridine Dicarboxamide SCHEMBL29587789 0.84 TSHR (0.59) ALDH1A1PIM1KDM4EALOX15TSHR
SCHEMBL960010 0.82 ALDH1A1 (0.51) ALDH1A1HPGDGRM5KDM4EALOX15
Pyridine Dicarboxamide SCHEMBL15347496 0.81 TSHR (0.56) ALDH1A1PIM1KDM4EALOX15TSHR
Pyridine Dicarboxamide SCHEMBL38659131 0.81 TSHR (0.56) ALDH1A1PIM1KDM4EALOX15TSHR
Pyridine Dicarboxamide SCHEMBL29031925 0.81 TSHR (0.56) ALDH1A1PIM1KDM4EALOX15TSHR
Pyridine Dicarboxamide SCHEMBL29501171 0.81 TSHR (0.56) ALDH1A1PIM1KDM4EALOX15TSHR
SCHEMBL4989 0.80 KDM4E (0.70) ALDH1A1HPGDGRM5KDM4EALOX15
SCHEMBL29940784 0.80 KDM4E (0.70) ALDH1A1HPGDGRM5KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115417814-A Synthetic method of 2-bromo-6-cyanopyridine 安徽大学 2022-12-02 CN claimed
CN-109593085-A Pyridine-amide-oxazoline ligand, its synthetic method and its metal complex and purposes 温州大学 2019-04-09 CN claimed
CN-105753775-A Synthesis method for 2-bromo-6-(3-(trifluoromethyl)phenoxy)pyridine 常州大学 2016-07-13 CN claimed
US-20150191462-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS NOVARTIS AG (CH) 2015-07-09 US claimed
EP-2867222-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS Novartis AG (CH) 2015-05-06 EP claimed
WO-2014002057-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS NOVARTIS AG (CH) 2014-01-03 WO claimed
CN-101704781-B Preparation method of amino pyridine bromide compound UNIV JIANGSU POLYTECHNIC 2012-05-30 CN claimed
EP-1844044-B1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-07-21 EP claimed
CN-101704781-A Preparation method of amino pyridine bromide compound UNIV JIANGSU POLYTECHNIC 2010-05-12 CN claimed
US-7678815-B2 Thiazole-4-carboxyamide derivatives HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
CN-101343366-A Nano-laminal compound with regular array of pyridine and its derivant, and preparation thereof UNIV SHANGHAI (CN) 2009-01-14 CN claimed
EP-1844044-A1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2007-10-17 EP claimed
US-20060160857-A1 Thiazole-4-carboxyamide derivatives HOFFMANN-LA ROCHE INC. 2006-07-20 US claimed
WO-2006074884-A1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-07-20 WO claimed
EP-3710428-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-25 EP disclosed
US-20250361244-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS AURIGENE ONCOLOGY LTD (IN) 2025-11-27 US disclosed
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-09-11 US disclosed
EP-1140849-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA 3 ADRENERGIC AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 EP disclosed
WO-2001068612-A2 ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINES AND TRIAZINES AND THE USE THEREOF EURO-CELTIQUE S.A. (LU) 2001-09-20 WO disclosed
WO-2000040560-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA 3 ADRENERGIC AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160857-A1 Thiazole-4-carboxyamide derivatives GRM1, GRM2, GRIA4 ALDH1A1 913/4885HPGD 3995/4885GRM5 4/4885
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB ALDH1A1 4167/4885HPGD 529/4885GRM5 2745/4885
US-20150191462-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS C5, TFPI, C9 ALDH1A1 1444/4885HPGD 410/4885GRM5 559/4885
US-20250361244-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS IRAK4, IRAK3, IRAK1 ALDH1A1 3272/4885HPGD 4072/4885GRM5 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.